Evidence map›Paper›PMID 42092839›Full record

ArticleBMC pulmonary medicine2026

Association between the endothelial activation and stress index and 28-day all-cause mortality in critically ill patients with chronic obstructive pulmonary disease: a retrospective cohort study and predictive model establishment based on machine learning.

Jianyi Niu, Qiaoyun Huang, Yanqi Dong, Shanshan Zha, Zhenfeng He, Luqian Zhou, Rongchang Chen, Lili Guan

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianyi Niu *Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Qiaoyun Huang *Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yanqi Dong *Development Center for Medical Science & Technology National Health Commission of the People's Republic of China, Beijing, China.
Shanshan ZhaGuangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhenfeng HeGuangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Luqian ZhouGuangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Rongchang ChenGuangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. chenrcstatekeylab@gmail.com.
Lili GuanGuangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. dr_nickguan@163.com.

Funding

Basic and Applied Basic Research Project of Guangzhou Municipal Science and Technology Bureau 2023A04J0571Basic Research Project of Guangzhou Municipal Science and Technology Bureau 2024A03J1202Guangdong Basic and Applied Basic Research Foundation 2022A1515110233Guangzhou Health Science, Technology Project of Guangzhou Municipal Health Commission 20231A011079National Natural Science Foundation of China 82200046Tertiary Education Scientific research project of Guangzhou Municipal Education Bureau 202235392
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) remains a major global health burden and is currently the third leading cause of death worldwide. Acute exacerbations accelerate disease progression and contribute substantially to mortality, underscoring the urgent need for reliable prognostic biomarkers. The endothelial activation and stress index (EASIX), a composite indicator of endothelial dysfunction, has demonstrated prognostic utility across diverse critical illnesses. However, its association with clinical outcomes in critically ill patients with COPD has not been clearly established.

methodsIn this retrospective cohort study, data of critically ill patients with COPD were extracted from the Medical Information Mart for Intensive Care (MIMIC) database. Participants were stratified into tertiles based on EASIX values, and intergroup differences in clinical characteristics were analyzed. The relationship between EASIX and 28-day all-cause mortality was examined using Kaplan-Meier survival analysis, Cox proportional hazards regression, and restricted cubic spline modeling. The Boruta algorithm was applied to assess the relative importance of candidate predictors, and prognostic models were subsequently developed using six machine learning algorithms.

resultsA total of 4,590 patients met the inclusion criteria. The incidence of 28-day ICU mortality increased progressively across higher EASIX tertiles (p < 0.001). EASIX was independently associated with 28-day ICU all-cause mortality, with both unadjusted and fully adjusted Cox models confirming this relationship (unadjusted HR = 1.21, p < 0.001; adjusted HR = 1.082, p < 0.001). Subgroup analyses demonstrated that the association between elevated EASIX and mortality risk remained consistent across demographic and comorbidity categories (p for interaction > 0.05 for all). The Boruta algorithm identified EASIX as one of the most important predictors of 28-day mortality. Among the six machine learning models evaluated, the XGBoost algorithm yielded the highest discriminative (AUC = 0.823), calibration and clinical application.

conclusionsEASIX serves as an independent prognostic marker for 28-day all-cause mortality in critically ill COPD patients. Furthermore, the EASIX-based machine learning model demonstrated strong predictive accuracy, supporting its potential as a valuable clinical tool or early risk stratification and decision-making in intensive care settings.

Indexed as

Critical IllnessEndothelium, VascularMachine LearningPulmonary Disease, Chronic ObstructiveAgedFemaleHumansIntensive Care UnitsKaplan-Meier EstimateMaleMiddle AgedPredictive Learning ModelsPrognosisProportional Hazards ModelsRetrospective StudiesChronic obstructive pulmonary diseaseEndothelial activation and stress indexMachine learningMortalityRisk factor

Identifiers

PMID42092839
PMCPMC13321682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.